Fidelity Disruptive Medicine ETF
FMED
7 hedge funds and large institutions have $27.9M invested in Fidelity Disruptive Medicine ETF in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, increasing their positions, 2 reducing their positions, and closing their positions.
133% more funds holding
Funds holding: 3 → 7 (+4)
40% more capital invested
Capital invested by funds: $19.9M → $27.9M (+$7.94M)
13.77% more ownership
Funds ownership: 45.64% → 59.41% (+14%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wealth Enhancement Advisory Services
Plymouth,
Minnesota
|
+$11.2M |
| 2 |
VF
Virtu Financial
New York
|
+$533K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$2.83K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.68K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$472K |
| 2 |
Jane Street
New York
|
-$82.3K |
FMED Hedge Fund Activity: Q3 2023 in Review
7 of the 6,312 institutional investors tracked by Wall St. Rank reported a position in Fidelity Disruptive Medicine ETF (FMED) for Q3 2023, worth a combined $27.9M — up 40% from $19.9M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new FMED positions and 0 closed out — a net gain of 4 holders — while 0 added to existing stakes and 2 trimmed.
The largest buyer was Wealth Enhancement Advisory Services, opening a new position worth an estimated $11.2M. The largest seller was Fidelity Investments, cutting an estimated $472K.
- 7 institutional investors held Fidelity Disruptive Medicine ETF (FMED) as of Q3 2023, up from 3 in Q2 2023.
- Funds reported $27.9M of Fidelity Disruptive Medicine ETF stock for Q3 2023, up 40% quarter-over-quarter.
- 4 funds opened new Fidelity Disruptive Medicine ETF positions in Q3 2023 and 0 closed out, a net change of +4 holders.
- The largest Fidelity Disruptive Medicine ETF buyer in Q3 2023 was Wealth Enhancement Advisory Services, an estimated $11.2M added.
- The largest Fidelity Disruptive Medicine ETF seller in Q3 2023 was Fidelity Investments, an estimated $472K sold.
Based on aggregated 13F filings for Q3 2023.